Concepedia

Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial

Dave Singh, Alberto Papi, Massimo Corradi, Ilona Pavlišová, Isabella Montagna, Catherine Francisco, Géraldine Cohuet, Stefano Vezzoli, Mario Scuri, Jørgen Vestbo

The Lancet · 2016 · 424 citations · 25 references

DOIFull text

Open access

Concepts

References

25

Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease

Peter Calverley, Julie A. Anderson, Bartolomé R. Celli et al. · New England Journal of Medicine · 2007 · 3.3K citations · Full text

, , +1

Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease

Gavin C. Donaldson · Thorax · 2002 · 2.3K citations · Full text

, , +17

A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease

Donald P. Tashkin, Bartolomé R. Celli, Stephen Senn et al. · New England Journal of Medicine · 2008 · 2.2K citations · Full text

, , +17

Indacaterol–Glycopyrronium versus Salmeterol–Fluticasone for COPD

Jadwiga A. Wedzicha, Donald Banerji, Kenneth R. Chapman et al. · New England Journal of Medicine · 2016 · 870 citations · Full text

, , +17

Effect of Pharmacotherapy on Rate of Decline of Lung Function in Chronic Obstructive Pulmonary Disease: Results from the TORCH Study

Bartolomé R. Celli, Nicola E. Thomas, Julie A. Anderson et al. · American Journal of Respiratory and Critical Care Medicine · 2008 · 746 citations

, , +17